Lives are at risk because women are not taking urgent cancer symptoms seriously during the pandemic, according to new research by Target Ovarian Cancer. Key ovarian cancer symptoms are of particular concern: Less than 2 in 10 women (17%) say they would book an urgent GP appointment (within a week) if they were experiencing persistent bloating. This […]
Read More… from Urgent ovarian cancer symptoms ignored during lockdown
How inflammatory signalling molecules contribute to carcinogenesis: A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection between an inflammatory signalling molecule and one of the main oncogenes. The study has […]
Read More… from How inflammatory signalling molecules contribute to carcinogenesis
An ‘immuno-storm chip’ developed by University of Queensland researchers could diagnose cancer and COVID-19 patients at risk of a potentially lethal reaction. The device was invented at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) by Professor Matt Trau, Dr Alain Wuethrich and Junrong Li. Professor Matt Trau and Dr Alain Wuethrich in the laboratory Professor Trau said the chip […]
Read More… from Chip detects over-reaction in cancer treatment
Word Cancer Day 2021 – the ultimate year of the ‘I Am And I Will’ World Cancer Day campaign – shows us that our actions have an impact on everyone around us, within our neighbourhoods, communities and cities. This year is a reminder of the enduring power of cooperation and collective action. When we […]
Testing, testing, testing – can blood tests help to detect early cancers? With the COVID-19 pandemic highlighting the importance of testing, and our capacity to undertake it at large scale, can we use these testing strategies for earlier diagnosis of cancer? By Professor Maarten IJzerman and Professor Sarah-Jane Dawson, University of Melbourne and Peter MacCallum […]
Read More… from Can blood tests help to detect early cancers
The Lady Garden Foundation is a national health charity on a mission to raise awareness and funding for gynaecological health. January marks Cervical Cancer Awareness Week (18-24th January) and a chance to shine the spotlight further on the importance of knowing the symptoms and seeking medical advice for any concerns. With over 500,000 women diagnosed […]
Charity calls for faster action on at-home cervical screening: New research conducted by Jo’s Cervical Cancer Trust1 during the pandemic has found that 32% of women would prefer to take an HPV self sample, than attend cervical screening with a clinician. Rising to 62% if it was easy and reliable. This week is Cervical Cancer Prevention […]
The true cost of chemotherapy: Chemotherapy for breast cancer costs the UK economy more than £248 million annually, including ‘out-of-pocket’ personal costs of more than £1,000 per patient – according to new research from the University of East Anglia. A new study published today is the first to investigate the total non-healthcare cost of chemotherapy […]
New mammogram measures of breast cancer risk could revolutionise screening: World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost. Published in the International Journal of Cancer, the University of Melbourne-led study found two new mammogram-based […]
Men and women: Cancer risk from obesity differs: A new study, co-funded by World Cancer Research Fund (WCRF), Cancer Research UK and Diabetes UK, reveals that where fat is on our body may lead to different health outcomes for men and women. The research revealed that having more body fat around your waist is more […]
Read More… from Men and women: Cancer risk from obesity differs